Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity.

导出 OA

翻译打印收藏纠错

第一作者： Gavin D,Garland

第一单位： MRC Toxicology Unit, Gleeson Building, Tennis Court Rd, Cambridge, U.K.

作者： Gavin D,Garland ^[1] ; Robert F,Harvey ^[1] ; Thomas E,Mulroney ^[1] ; Mie,Monti ^[1] ; Stewart,Fuller ^[2] ; Richard,Haigh ^[3] ; Pehuén Pereyra,Gerber ^[4] ; Michael R,Barer ^[3] ; Nicholas J,Matheson ^[5] ; Anne E,Willis ^[1]

作者单位： MRC Toxicology Unit, Gleeson Building, Tennis Court Rd, Cambridge, U.K. ^[1] Department of Medicine, University of Cambridge, Cambridge, U.K. ^[2] Department of Respiratory Sciences, Maurice Shock Medical Sciences Building, University Road, Leicester, U.K. ^[3] Department of Medicine, University of Cambridge, Cambridge, U.K.;Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, U.K. ^[4] Department of Medicine, University of Cambridge, Cambridge, U.K.;Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, Cambridge, U.K.;NHS Blood and Transplant, Cambridge, U.K. ^[5]

关键词 COVID 19 Coronavirus assay development